Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

Pain, Post-operative Clinical Trial

Official title:
A Phase 2, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety, Efficacy, and Pharmacokinetics of N1539 Following Bunionectomy

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the safety of N1539 in subjects with acute moderate to severe pain following unilateral bunionectomy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02540265
Study type	Interventional
Source	Recro Pharma, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	August 2015
Completion date	November 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02284243` - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery	Phase 2
Completed	`NCT02720692` - Evaluation of N1539 Following Major Surgery	Phase 3
Completed	`NCT03456141` - Multimodal Analgesic Protocol to Moderate Acute Pain
Terminated	`NCT02169336` - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy	Phase 2
Not yet recruiting	`NCT05950152` - Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery	Phase 2
Completed	`NCT02678286` - Evaluation of N1539 Following Abdominoplasty Surgery	Phase 3
Completed	`NCT02675907` - Evaluation of N1539 Following Bunionectomy Surgery	Phase 3
Unknown status	`NCT01041313` - Memantine for Post-Operative Pain Control	Phase 4
Completed	`NCT03154658` - Serratus Anterior Plane Block in Patients Undergoing Mastectomy	Phase 4